DJIA52215.16 -652.82
S&P 5007623.68 -39.75
NASDAQ25955.34 -53.52
Russell 20002775.90 -8.13
German DAX25181.65 -190.10
FTSE 10010690.36 -34.67
CAC 407782.82 -28.44
EuroStoxx 506065.15 -20.80
Nikkei 22562189.65 -503.51
Hang Seng23093.37 158.69
Shanghai Comp3690.48 32.45
KOSPI5469.47 -80.83
Bloomberg Comm IDX143.69 1.01
WTI Crude-fut114.92 -1.99
Brent Crude-fut100.97 -2.74
Natural Gas2.55 -0.08
Gasoline-fut3.22 0.01
Gold-fut4030.80 20.80
Silver-fut54.17 0.21
Platinum-fut1547.70 -8.10
Palladium-fut1051.00 4.50
Copper-fut6.52 0.03
Aluminum-spot3195.00 0.00
Coffee-fut298.40 -7.60
Soybeans-fut1245.00 -24.50
Wheat-fut623.75 -1.25
Bitcoin80327.80 -727.24
Ethereum USD2329.17 -53.59
Litecoin56.69 -0.88
Dogecoin0.08 0.00
EUR/USD1.1201 -0.0014
USD/JPY157.03 -0.02
GBP/USD1.3372 0.0004
USD/CHF0.8259 0.0027
USD IDX101.90 0.15
US 10-Yr TR4.988 0
GER 10-Yr TR3.3626 0.0197
UK 10-Yr TR5.325 -0.0362
JAP 10-Yr TR2.793 0.006
Fed Funds4 0
SOFR3.92 0.02
High-rise commercial buildings

Sub Markets

Topics

Alternative Assets  + Private Equity  | 
Patient Square Reportedly Targeting $6B Raise for 2nd Fund

Patient Square Reportedly Targeting $6B Raise for 2nd Fund

Patient Square Capital, the healthcare-focused private equity firm founded by former global investment giant KKR dealmaker Jim Momtazee, is apparently back in the market with a massive second fund.

Last year, the firm raised $3.9 billion for its first fund, which is believed to be the largest vehicle ever raised by a dedicated health-care-focused private equity, growth equity or venture capital firm, and is now gathering commitments for a second fund with a target of more than $6 billion, according to PitchBook.

It stated that limited partners (LPs) from its inaugural fund, including Goldman Sachs, had already committed to the second fund, citing an anonymous source.

Many private equity firms that are now fundraising are dealing with macroeconomic worries such as a delayed exit market, which leaves LPs with less distributed capital to deploy in new funds.

Patient Square focuses on a wide range of healthcare industry subsectors, including development-stage therapies, commercial-stage pharmaceuticals, medical devices, technology-enabled services, and healthcare providers.

Connect

Inside The Story

Patient Square Capital

About Joe Palmisano

Joe Palmisano is editorial director of Connect Money, where he oversees daily coverage of alternative assets, direct investments, financial advisory and the economy. He brings three decades of experience as a financial journalist, analyst and portfolio manager. Before joining Connect Money, Palmisano wrote for The Wall Street Journal, covering foreign exchange, global fixed-income and equity markets. He later served as a senior research analyst and portfolio manager, producing market analysis and managing foreign exchange and U.S. equity portfolios for FX Concepts. His work has also appeared in SFO Magazine and CMT Association publications. Palmisano earned a bachelor’s degree in finance from The American University and holds the Chartered Market Technician (CMT) designation and is a member of the CFA Institute.